Drug companies spend millions to keep charging high prices

Pharmaceutical heavyweight Mylan, the latest poster child for drug-industry greed, finally stuck up for itself Thursday. It argued that “the system,” not avarice, was to blame for the company jacking up the price of EpiPens, a common (and life-saving) allergy remedy, by over 400%.
Read more: http://www.latimes.com/business/lazarus/la-fi-lazarus-drug-prices-20160826-snap-story.html?source=Snapzu